These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 33982405)

  • 1. Effect of difelikefalin, a selective kappa opioid receptor agonist, on respiratory depression: A randomized, double-blind, placebo-controlled trial.
    Viscusi ER; Torjman MC; Munera CL; Stauffer JW; Setnik BS; Bagal SN
    Clin Transl Sci; 2021 Sep; 14(5):1886-1893. PubMed ID: 33982405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of renal impairment on the pharmacokinetic profile of intravenous difelikefalin, a kappa opioid receptor agonist for the treatment of pruritus.
    Spencer RH; Noonan PK; Marbury T; Menzaghi F
    BMC Nephrol; 2024 Oct; 25(1):351. PubMed ID: 39402448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the abuse potential of difelikefalin, a selective kappa-opioid receptor agonist, in recreational polydrug users.
    Shram MJ; Spencer RH; Qian J; Munera CL; Lewis ME; Henningfield JE; Webster L; Menzaghi F
    Clin Transl Sci; 2022 Feb; 15(2):535-547. PubMed ID: 34708917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase 2 Trial of Difelikefalin in Notalgia Paresthetica.
    Kim BS; Bissonnette R; Nograles K; Munera C; Shah N; Jebara A; Cirulli J; Goncalves J; Lebwohl M;
    N Engl J Med; 2023 Feb; 388(6):511-517. PubMed ID: 36780675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus.
    Fishbane S; Jamal A; Munera C; Wen W; Menzaghi F;
    N Engl J Med; 2020 Jan; 382(3):222-232. PubMed ID: 31702883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Difelikefalin in Japanese Patients With Moderate to Severe Pruritus Receiving Hemodialysis: A Randomized Clinical Trial.
    Narita I; Tsubakihara Y; Uchiyama T; Okamura S; Oya N; Takahashi N; Gejyo F;
    JAMA Netw Open; 2022 May; 5(5):e2210339. PubMed ID: 35511180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase 2 study of oral difelikefalin in subjects with chronic kidney disease and moderate-to-severe pruritus.
    Yosipovitch G; Awad A; Spencer RH; Munera C; Menzaghi F
    J Am Acad Dermatol; 2023 Aug; 89(2):261-268. PubMed ID: 37059302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the physical dependence potential of difelikefalin: Randomized placebo-controlled study in patients receiving hemodialysis.
    Spencer RH; Munera C; Shram MJ; Menzaghi F
    Clin Transl Sci; 2023 Sep; 16(9):1559-1568. PubMed ID: 37128642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, tolerability, pharmacokinetics, and pharmacodynamics of a novel kappa opioid receptor agonist ZYKR1: a randomized double-blind placebo-control phase 1 study in healthy adult human participants.
    Kansagra KA; Momin T; Patel HB; Shah C; Parmar G; Ghoghari A; Patel HV; Parmar DV
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):4737-4745. PubMed ID: 38141084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Tolerability of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis From the Phase 3 Clinical Trial Program.
    Fishbane S; Wen W; Munera C; Lin R; Bagal S; McCafferty K; Menzaghi F; Goncalves J
    Kidney Med; 2022 Aug; 4(8):100513. PubMed ID: 36039153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difelikefalin for Hemodialysis Patients with Pruritus in Japan.
    Narita I; Tsubakihara Y; Takahashi N; Ebata T; Uchiyama T; Marumo M; Okamura S; Gejyo F;
    NEJM Evid; 2023 Nov; 2(11):EVIDoa2300094. PubMed ID: 38320524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
    Antonijoan R; García-Gea C; Puntes M; Pérez J; Esbrí R; Serra C; Fortea J; Barbanoj MJ
    Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized Controlled Trial of Difelikefalin for Chronic Pruritus in Hemodialysis Patients.
    Fishbane S; Mathur V; Germain MJ; Shirazian S; Bhaduri S; Munera C; Spencer RH; Menzaghi F;
    Kidney Int Rep; 2020 May; 5(5):600-610. PubMed ID: 32405581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of supplemental oxygen during emergency department procedural sedation and analgesia with midazolam and fentanyl: a randomized, controlled trial.
    Deitch K; Chudnofsky CR; Dominici P
    Ann Emerg Med; 2007 Jan; 49(1):1-8. PubMed ID: 16978741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difelikefalin in Black/African American Hemodialysis Patients with Moderate-to-Severe Pruritus: Post hoc Analysis of KALM-1 and KALM-2.
    Fishbane S; Clegg DJ; Lerma EV; Rastogi A; Budden J; Morin I; Wen W; Menzaghi F; Topf J
    Am J Nephrol; 2024; 55(3):329-333. PubMed ID: 38253036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difelikefalin: First Approval.
    Deeks ED
    Drugs; 2021 Nov; 81(16):1937-1944. PubMed ID: 34674115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Effectiveness of Difelikefalin in Patients With Moderate-to-Severe Pruritus Undergoing Hemodialysis: An Open-Label, Multicenter Study.
    Weiner DE; Vervloet MG; Walpen S; Schaufler T; Munera C; Menzaghi F; Wen W; Bhaduri S; Germain MJ;
    Kidney Med; 2022 Oct; 4(10):100542. PubMed ID: 36185706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of difelikefalin in the treatment of hemodialysis patients with pruritus: A meta-analysis and systematic review.
    Xue G; Yuan H; Fan D; Yang Y; Ma C; Liu J; Liao R
    Clin Nephrol; 2024 Apr; 101(4):155-163. PubMed ID: 38294219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis of KALM-1 and KALM-2 Phase 3 Studies.
    Topf J; Wooldridge T; McCafferty K; Schömig M; Csiky B; Zwiech R; Wen W; Bhaduri S; Munera C; Lin R; Jebara A; Cirulli J; Menzaghi F
    Kidney Med; 2022 Aug; 4(8):100512. PubMed ID: 36016762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.